Cargando…

Prognostic Value of VEGF in Human Pancreatic Ductal Adenocarcinoma

BACKGROUND : Since pancreatic cancer metastasizes early regardless of the size of the primary tumor, it is suggested that angiogenic factor is upregulated in this disease. Among the angiogenic factors, vascular endothelial growth factor (VEGF) is the most potent and specific growth factor. The aim o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lim, Yun Jeong, Lee, Jong Kyun, Park, Cheol Keun, Song, Sang Yong, Jang, Woo Young, Ha, Hye Young, Park, Dong Il, Lee, Kyu Taek, Paik, Seung Woon, Yoo, Byung Chul, Rhee, Jong Chul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Association of Internal Medicine 2004
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4531550/ https://www.ncbi.nlm.nih.gov/pubmed/15053037 http://dx.doi.org/10.3904/kjim.2004.19.1.10

Ejemplares similares

Prognostic Significance of Maspin in Pancreatic Ductal Adenocarcinoma
por: Lim, Yun Jeong, et al.
Publicado: (2004)

Factors of Endoscopic Ultrasound-Guided Tissue Acquisition for Successful Next-Generation Sequencing in Pancreatic Ductal Adenocarcinoma
por: Park, Jae Keun, et al.
Publicado: (2020)

Expression of cyclooxygenase-2 and its correlation with clinicopathologic factors of ampulla of vater cancer.
por: Kim, Hong Joo, et al.
Publicado: (2003)

Role of Hyperinsulinemia and Glucose Intolerance in the Pathogenesis of Nonalcoholic Fatty Liver in Patients with Normal Body Weight
por: Lee, Joon Hyoek, et al.
Publicado: (1998)

Validation of IL-7R as an Immunological Biomarker for Human Pancreatic Ductal Adenocarcinoma
por: Jang, Sung-Ill, et al.
Publicado: (2022)

Detection of Circulating Tumor Cells in Resectable Pancreatic Ductal Adenocarcinoma: A Prospective Evaluation as a Prognostic Marker
por: Song, Byeong Geun, et al.
Publicado: (2021)

Behavior of Small, Asymptomatic, Nonfunctioning Pancreatic Neuroendocrine Tumors (NF-PNETs)
por: Jung, Jae Gu, et al.
Publicado: (2015)

KRAS mutation analysis of washing fluid from endoscopic ultrasound-guided fine needle aspiration improves cytologic diagnosis of pancreatic ductal adenocarcinoma
por: Park, Kyung Joo, et al.
Publicado: (2016)

Accurate Prognosis Prediction of Pancreatic Ductal Adenocarcinoma Using Integrated Clinico-Genomic Data of Endoscopic Ultrasound-Guided Fine Needle Biopsy
por: Park, Joo Kyung, et al.
Publicado: (2021)

Genetic assessment of pathogenic germline alterations in lysosomal genes among Asian patients with pancreatic ductal adenocarcinoma
por: Koh, Youngil, et al.
Publicado: (2023)

Clinical significance of circulating tumor cells after chemotherapy in unresectable pancreatic ductal adenocarcinoma
por: Kim, Hyemin, et al.
Publicado: (2021)

A comparison of the clinical outcomes of patients with invasive lobular carcinoma and invasive ductal carcinoma of the breast according to molecular subtype in a Korean population
por: Lim, Seung Taek, et al.
Publicado: (2014)

Hepatoid adenocarcinoma of the stomach: an unusual case of elevated alpha-fetoprotein with prior treatment for hepatocellular carcinoma
por: Ahn, Joon Seong, et al.
Publicado: (2013)

Serum interleukin-6 is associated with pancreatic ductal adenocarcinoma progression pattern
por: Kim, Hyoung Woo, et al.
Publicado: (2017)

Identification of Factors that Influence Conscious Sedation in Gastrointestinal Endoscopy
por: Lee, Sun-Young, et al.
Publicado: (2004)

Prognostic Index for Portal Vein Tumor Thrombosis in Patients with Hepatocellular Carcinoma Treated with Radiation Therapy
por: Yu, Jeong Il, et al.
Publicado: (2011)

Arterial resection during pancreatectomy for pancreatic ductal adenocarcinoma with arterial invasion: A single-center experience with 109 patients
por: Kwon, Jaewoo, et al.
Publicado: (2020)

Initial Metastatic Site as a Prognostic Factor in Patients With Stage IV Pancreatic Ductal Adenocarcinoma
por: Kim, Hyoung Woo, et al.
Publicado: (2015)

A Case of Osteoclast-like Giant Cell Tumor of the Pancreas with Ductal Adenocarcinoma: Histopathological, Immunohistochemical, Ultrastructural and Molecular Biological Studies
por: Joo, Young-Eun, et al.
Publicado: (2005)

Prediction of Complete Necrosis of Hepatocellular Carcinoma Treated with Transarterial Chemoembolization Prior to Liver Transplantation
por: Kim, Sue Jin, et al.
Publicado: (2009)

Inhibition of VEGF‐dependent angiogenesis and tumor angiogenesis by an optimized antibody targeting CLEC14a
por: Kim, Taek‐Keun, et al.
Publicado: (2018)

Biomarker Panel for the Diagnosis of Pancreatic Ductal Adenocarcinoma
por: Kim, Hongbeom, et al.
Publicado: (2020)

What is Currently the Best for Adenocarcinoma without Driver Mutation?
por: Park, Cheol-Kyu, et al.
Publicado: (2018)

Scheduled Interval Trans-Catheter Arterial Chemoembolization Followed by Radiation Therapy in Patients with Unresectable Hepatocellular Carcinoma
por: Yu, Jeong Il, et al.
Publicado: (2012)

The Impact of Surgical Timing on Pathologic Tumor Response after Short Course and Long Course Preoperative Chemoradiation for Locally Advanced Rectal Adenocarcinoma
por: Lee, Sea-Won, et al.
Publicado: (2018)

The transcriptional landscape and mutational profile of lung adenocarcinoma
por: Seo, Jeong-Sun, et al.
Publicado: (2012)

Comparison of Characteristics and Survival Rates of Resectable Pancreatic Ductal Adenocarcinoma according to Tumor Location
por: Sung, Min Kyu, et al.
Publicado: (2021)

Case report of prostate ductal adenocarcinoma presenting with hematuria
por: Pawlowski, Jamie, et al.
Publicado: (2018)

Feasibility of in vivo swine models using guide wire-assisted intraductal radiofrequency ablation for benign biliary stricture
por: Park, Jae Keun, et al.
Publicado: (2023)

Increased VEGF-A in solid type of lung adenocarcinoma reduces the patients’ survival
por: Jung, Woon Yong, et al.
Publicado: (2021)

Circulating tumour cells as an indicator of early and systemic recurrence after surgical resection in pancreatic ductal adenocarcinoma
por: Park, Yejong, et al.
Publicado: (2021)

Association between Metformin Use and Clinical Outcomes Following Pancreaticoduodenectomy in Patients with Type 2 Diabetes and Pancreatic Ductal Adenocarcinoma
por: Yoo, Daegwang, et al.
Publicado: (2020)

Validation of the eighth edition of the American Joint Committee on Cancer staging system and proposal of an improved staging system for pancreatic ductal adenocarcinoma
por: Park, Min Young, et al.
Publicado: (2019)

The Role of Vascular Endothelial Growth Factor (VEGF) and p53 Status for Angiogenesis in Gastric Cancer
por: Joo, Young Eun, et al.
Publicado: (2002)

Overlapping Gene Mutations of Hepatitis B Virus in a Chronic Hepatitis B Patient with Hepatitis B Surface Antigen Loss during Lamivudine Therapy
por: Lee, Sun-Young, et al.
Publicado: (2005)

Comparison of Minimally Invasive versus Open Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: A Propensity Score Matching Analysis
por: Kwon, Jaewoo, et al.
Publicado: (2020)

Is Health Screening Beneficial for Early Detection and Prognostic Improvement in Pancreatic Cancer?
por: Kim, Eun Ran, et al.
Publicado: (2011)

Gene Therapy Using Nanocarriers for Pancreatic Ductal Adenocarcinoma: Applications and Challenges in Cancer Therapeutics
por: Won, Eun-Jeong, et al.
Publicado: (2022)

Correlation of mutation and immunohistochemistry of p53 in hepatocellular carcinomas in Korean people.
por: Lee, Shi Nae, et al.
Publicado: (2002)

Prognostic significance of miR-122 expression after curative resection in patients with hepatocellular carcinoma
por: Ha, Sang Yun, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_7glaergvp7a0ma7uh1aebmtfm5